UFEB vs. BOUT
Compare and contrast key facts about Innovator U.S. Equity Ultra Buffer ETF - February (UFEB) and Innovator IBD Breakout Opportunities ETF (BOUT).
UFEB and BOUT are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. UFEB is a passively managed fund by Innovator that tracks the performance of the Cboe S&P 500 30% (-5% to -35%) Buffer Protect February Series Index. It was launched on Jan 31, 2020. BOUT is a passively managed fund by Innovator that tracks the performance of the IBD Breakout Stocks Total Return Index. It was launched on Sep 13, 2018. Both UFEB and BOUT are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
UFEB vs. BOUT - Performance Comparison
Loading graphics...
UFEB vs. BOUT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
UFEB Innovator U.S. Equity Ultra Buffer ETF - February | -1.32% | 10.57% | 12.93% | 11.91% | -5.85% | 7.31% | 5.78% |
BOUT Innovator IBD Breakout Opportunities ETF | 8.23% | -6.77% | 18.82% | 13.27% | -22.60% | 22.69% | 48.23% |
Returns By Period
In the year-to-date period, UFEB achieves a -1.32% return, which is significantly lower than BOUT's 8.23% return.
UFEB
- 1D
- 1.23%
- 1M
- -2.29%
- YTD
- -1.32%
- 6M
- 1.42%
- 1Y
- 12.07%
- 3Y*
- 11.00%
- 5Y*
- 6.14%
- 10Y*
- —
BOUT
- 1D
- 2.67%
- 1M
- -3.79%
- YTD
- 8.23%
- 6M
- 1.15%
- 1Y
- 8.69%
- 3Y*
- 8.84%
- 5Y*
- 4.03%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
UFEB vs. BOUT - Expense Ratio Comparison
UFEB has a 0.79% expense ratio, which is lower than BOUT's 0.80% expense ratio.
Return for Risk
UFEB vs. BOUT — Risk / Return Rank
UFEB
BOUT
UFEB vs. BOUT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innovator U.S. Equity Ultra Buffer ETF - February (UFEB) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UFEB | BOUT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.59 | 0.40 | +1.19 |
Sortino ratioReturn per unit of downside risk | 2.32 | 0.66 | +1.65 |
Omega ratioGain probability vs. loss probability | 1.35 | 1.09 | +0.26 |
Calmar ratioReturn relative to maximum drawdown | 2.51 | 0.65 | +1.86 |
Martin ratioReturn relative to average drawdown | 11.91 | 1.81 | +10.10 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| UFEB | BOUT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.59 | 0.40 | +1.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.99 | 0.21 | +0.78 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.84 | 0.30 | +0.55 |
Correlation
The correlation between UFEB and BOUT is 0.65, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
UFEB vs. BOUT - Dividend Comparison
UFEB has not paid dividends to shareholders, while BOUT's dividend yield for the trailing twelve months is around 0.32%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
UFEB Innovator U.S. Equity Ultra Buffer ETF - February | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BOUT Innovator IBD Breakout Opportunities ETF | 0.32% | 0.34% | 0.60% | 1.32% | 1.35% | 0.00% | 0.00% | 0.00% | 0.22% |
Drawdowns
UFEB vs. BOUT - Drawdown Comparison
The maximum UFEB drawdown since its inception was -13.32%, smaller than the maximum BOUT drawdown of -36.75%. Use the drawdown chart below to compare losses from any high point for UFEB and BOUT.
Loading graphics...
Drawdown Indicators
| UFEB | BOUT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -13.32% | -36.75% | +23.43% |
Max Drawdown (1Y)Largest decline over 1 year | -4.95% | -13.73% | +8.78% |
Max Drawdown (5Y)Largest decline over 5 years | -9.02% | -28.28% | +19.26% |
Current DrawdownCurrent decline from peak | -2.72% | -6.50% | +3.78% |
Average DrawdownAverage peak-to-trough decline | -1.97% | -12.55% | +10.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.04% | 4.95% | -3.91% |
Volatility
UFEB vs. BOUT - Volatility Comparison
The current volatility for Innovator U.S. Equity Ultra Buffer ETF - February (UFEB) is 2.44%, while Innovator IBD Breakout Opportunities ETF (BOUT) has a volatility of 8.61%. This indicates that UFEB experiences smaller price fluctuations and is considered to be less risky than BOUT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| UFEB | BOUT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 2.44% | 8.61% | -6.17% |
Volatility (6M)Calculated over the trailing 6-month period | 4.25% | 17.18% | -12.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 7.62% | 21.74% | -14.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 6.25% | 19.54% | -13.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 7.73% | 22.96% | -15.23% |